info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • All Products

    OUR PRODUCTS

    Allieva Pharma offers a wide range of pharmaceutical products including tablets, capsules, and injections. Our products are manufactured with high-quality standards and trusted across India and international markets.

    PALBOLIEVA 100MG Palbolieva Capsules 100mg by Allieva Pharma Private Limited

    PALBOLIEVA 100MG

    Palbolieva Capsules 100mg

    PALBOLIEVA 100 mg contains Palbociclib, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor. It works by inhibiting CDK4 and CDK6, leading to cell-cycle arrest in the G1 phase and suppression of cancer cell proliferation, particularly in hormone receptor–positive breast cancer.

    View Details
    ENZALIEVA 40MG Enzalutamide Capsules 40mg by Allieva Pharma Private Limited

    ENZALIEVA 40MG

    Enzalutamide Capsules 40mg

    ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.

    View Details
    ENZALIEVA 40MG Enzalutamide Capsules 40mg by Allieva Pharma Private Limited

    ENZALIEVA 40MG

    Enzalutamide Capsules 40mg

    ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.

    View Details
    PARIBLIEVA 150MG Olaparib Tablets 150mg by Allieva Pharma Private Limited

    PARIBLIEVA 150MG

    Olaparib Tablets 150mg

    PARIBLIEVA 150 mg contains Olaparib, an oral PARP (Poly ADP-ribose polymerase) inhibitor. It blocks DNA repair in cancer cells, especially those with BRCA1/BRCA2 mutations, leading to accumulation of DNA damage and selective cancer cell death (synthetic lethality).

    View Details
    LENVALIEVA 10MG Lenvatinib Capsules 10mg by Allieva Pharma Private Limited

    LENVALIEVA 10MG

    Lenvatinib Capsules 10mg

    LENVALIEVA 10 mg contains Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI). It blocks receptors involved in tumor angiogenesis and growth, including VEGFR 1–3, FGFR 1–4, PDGFR-α, RET, and KIT, leading to inhibition of tumor blood vessel formation and cancer cell proliferation. 

    View Details
    LENVALIEVA 4MG Lenvatinib Capsules 4mg by Allieva Pharma Private Limited

    LENVALIEVA 4MG

    Lenvatinib Capsules 4mg

    LENVALIEVA 4 mg contains Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI). It inhibits multiple receptors involved in tumor growth and angiogenesis, including VEGFR 1–3, FGFR 1–4, PDGFR-α, RET, and KIT, thereby suppressing tumor vascularization and proliferation.

    View Details
    TROMLIEVA 50MG Eltrombopag Olamine Tablets 50mg by Allieva Pharma Private Limited

    TROMLIEVA 50MG

    Eltrombopag Olamine Tablets 50mg

    TROMLIEVA 50 mg contains Eltrombopag Olamine, an oral thrombopoietin (TPO) receptor agonist. It increases platelet production by stimulating the c-Mpl receptor on megakaryocyte progenitor cells in the bone marrow, thereby raising platelet counts.

    View Details
    TROMLIEVA 25MG Eltrombopag Olamine Tablets 25mg by Allieva Pharma Private Limited

    TROMLIEVA 25MG

    Eltrombopag Olamine Tablets 25mg

    TROMLIEVA 25 mg contains Eltrombopag Olamine, an oral thrombopoietin (TPO) receptor agonist. It stimulates platelet production by activating the c-Mpl receptor on megakaryocyte precursors in the bone marrow, leading to increased platelet counts.  

    View Details
    TEMALIEVA 250MG Temozolomide Capsules IP 250mg by Allieva Pharma Private Limited

    TEMALIEVA 250MG

    Temozolomide Capsules IP 250mg

    TEMALIEVA 250 mg contains Temozolomide, an oral alkylating chemotherapy agent. It damages tumor cell DNA by methylation, leading to inhibition of DNA replication and cell death. Because it crosses the blood–brain barrier, it is especially effective for malignant brain tumors.

    View Details
    TEMALIEVA 100MG Temozolomide Capsules IP 100mg by Allieva Pharma Private Limited

    TEMALIEVA 100MG

    Temozolomide Capsules IP 100mg

    TEMALIEVA 100 mg contains Temozolomide, an oral alkylating chemotherapy agent. It works by methylating DNA, causing DNA damage and apoptosis of rapidly dividing tumor cells. Temozolomide crosses the blood–brain barrier, making it highly effective in treating brain tumors.

    View Details
    TEMALIEVA 20MG Temozolomide Capsules IP 20mg by Allieva Pharma Private Limited

    TEMALIEVA 20MG

    Temozolomide Capsules IP 20mg

    TEMALIEVA 20 mg contains Temozolomide, an oral alkylating chemotherapy agent. It works by methylating DNA, leading to DNA damage and apoptosis of rapidly dividing tumor cells. Temozolomide readily crosses the blood–brain barrier, making it especially effective for brain tumors.

    View Details
    LENALIEVA 25MG Lenalidomide Capsules 25mg by Allieva Pharma Private Limited

    LENALIEVA 25MG

    Lenalidomide Capsules 25mg

    LENALIEVA 25 mg contains Lenalidomide, an immunomodulatory anticancer drug (IMiD). It works by modulating the immune system, inhibiting cancer cell proliferation, reducing angiogenesis, and inducing apoptosis of malignant cells. It is a potent analogue of thalidomide with improved efficacy.

    View Details

    24/7 Clients Support

    Best Price

    Quality Assurance